Ayurvedic treatment of Paralysis

A COMPARATIVE CLINICO-EXPERIMENTAL STUDY TO EVALUATE EFFICACY OF VIRECHANA AND KAALA BASTI ALONG WITH SHAMANA THERAPY IN THE MANAGEMENT OF PAKSHAGHATA

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/05/008497

Enrollment

Registered

2017-05-05

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- paralysed patients

Interventions

Intervention1: virechana followed by shamana drug: patients in this group will be given classical virechana karma followed by shamana drug in which masha baladi kashaya 100 ml twice a day Interventi

Eligibility

Inclusion criteria

Inclusion criteria: diagnosed cases of pakshaghata yogya for virechana and basti karma

Exclusion criteria

Exclusion criteria: degenerative lesions intracranial infection intra cranial spae ocupying lesion

Design outcomes

Primary

Measure	Time frame
to improve the disability produced by pakshaghataTimepoint: 7 to 8 weeks	—

Secondary

Measure	Time frame
to improve quality of life of patients and assess signs and symptoms after four weeksTimepoint: four weeks	—

Countries

India

Contacts

Public ContactDr Anup B Thakar

Institute for Post Graduate Teaching and Research in Ayurveda Jamnagar Gujarat

adil.rais13@gmail.com7060272769

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026